MENU
ARDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ardelyx (ARDX) Ownership - Who owns Ardelyx?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
400 Fifth Avenue
Phone
+1 510 745-1700
Employees
267
Web
https://www.ardelyx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.1B
P/E Ratio
N/A
Total Cash
190.4M
Projected Growth
N/A
Total Debt
104.49M
Revenue
251.85M
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash/Share
0.80
Total Debt/Equity
N/A
Revenue/Share
1.08 USD as % of share price
Fundamentals
ARDX
Capitalization
1.1B
P/E Ratio
N/A
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash
190M
Total Cash/Share
0.80
Total Debt
104M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.08%
Revenue
252M
ROE
N/A
Book Value
158M
P/B Ratio
6.97
Cash Flow
N/A
Earnings
-0.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
24K
Current Ratio
4.03
Current Revenue Per Employee
367943.80
Dividends Per Share - Security
N/A
EBITDA
-53.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
83.99
Revenue To Assets
-22.09
Shares Held By Institutions
1.78B
Shares Outstanding - Current
237M
Total Liabilities
210M
Total Volume MTD
N/A
Value
-1
Gain YTD
-24.839
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Fifth Avenue
Phone
+1 510 745-1700
Employees
267
Web
https://www.ardelyx.com